1.Antenatal Myomectomy: Is It Safe?
Nor Amirawati A ; Anizah A ; Shafiee MN
Journal of Surgical Academia 2017;7(2):46-48
2.Intraperitoneal Chemotherapy Following Refractory Intravenous Route in Advanced Ovarian Cancer
Shafiee MN ; Omar MH ; Suraya A ; Hatta M
Journal of Surgical Academia 2013;3(1):28-31
Platinum based adjuvant chemotherapy is generally recommended for ovarian cancer to improve the survival rate.
Intravenous route is commonly used, easily administered and less associated complications. However, intraperitoneal
route is gaining its popularity as a single procedure or adjunctive to the intravenous route. Numerous questions on its
eligibility and safety are still perplexed. A case review on a patient with non optimal debulking surgery of advanced
ovarian cancer was studied. Intravenous platinum based chemotherapy combined with paclitaxel failed to bring her
to clinical remission. Second line chemotherapy, gemcitabin rendered her to poor response with unresolved
debilitating ascites needing recurrent drainage. Surprisingly, a trial of intraperitoneal chemotherapy with cisplatin
revealed a great response with a complete clinical remission.
3.Cervical Ectopic Pregnancy: A Management Dilemma
Shafiee MN ; Norliza I ; Lim PS ; Shuhaila A ; Mohd Hashim O
Journal of Surgical Academia 2012;2(1):30-33
A 28-year-old G3P1+1 at 6 weeks period of amenorrhea with a previous Caesarean section presented with per vaginal bleeding. A cervical ectopic pregnancy was confirmed by a transvaginal scan. An intramuscular methotrexate was given followed by intracervical route due to poor decline of the serum βHCG. However, due to persistent increment of serum βHCG, an additional four doses of intramuscular methotrexate with folinic acid rescue were administered and she responded well to the regime. Unfortunately, following the last dose, she developed an episode of excessive per vaginal bleeding which required suction and curettage of the cervical canal. A Foley‘s catheter balloon was placed intracervically as a tamponade and the bleeding was successfully arrested.
4.‘Emergency Chemotherapy’ for Bleeding Cervical Cancer: Case Series
Shafiee MN ; NorAzlin MI ; Lim PS ; Trika I ; Arifuddin D ; Hatta D
Journal of Surgical Academia 2012;2(2):35-37
Fulminant haemorrhage in cervical cancer leads to severe anaemia and haemodynamic instability. Palliative management includes vaginal packing as temporary measure, radiotherapy and other invasive surgical procedures. High dose emergency chemotherapy is not commonly implemented particularly when complicated with anaemia and renal impairment. We discuss three case series on the usefulness of high dose chemotherapy to combat bleeding from cervical cancer as an emergency treatment. The first case was clinically staged as operable 2A disease with severe anaemia due to bleeding from the tumour mass. The haemoglobin was corrected by blood transfusion while the bleeding was being arrested by high dose chemotherapy. The second case was inoperable with invasion to the bladder mucosa. She had frank haematuria and bleeding from the tumour with severe anaemia. A course of chemotherapy and blood transfusion controlled the bleeding and anaemia was corrected. The third case presented late with obstructive uropathy and anaemia. She required dialysis, blood transfusion and high dose emergency chemotherapy to stop the bleeding before undergoing urinary diversion after an unsuccessful ureteric stenting. High dose chemotherapy consisting cisplatin, vincristine, bleomycin and mitomycin-C has a clinical value in arresting fulminant haemorrhage in cervical cancer.
5.Re-Evaluation of Serum Beta Human Chorionic Gonadotropin Follow Up in Patients with Molar Pregnancy
Harry SR ; Nirmala CK ; Nor Azlin MI ; Lim PS ; Shafiee MN ; Shamsul AS ; Omar MH ; Hatta MD
Journal of Surgical Academia 2012;2(2):1-1
Continued follow up of uncomplicated molar cases beyond obtaining one undetectable serum β-hCG level is not necessary in order to detect relapse of gestational trophoblastic disease
6.Dislodged Levornogestrel-Intrauterine System Intra-Abdominally without Uterine Perforation: Is it Possible?
Ng BK ; Lim PS ; Shahizon AMM ; Ng YL ; Shafiee MN ; Omar MH
Journal of Surgical Academia 2016;6(1):51-53
We report a case of dislodged Levornogestrel-intrauterine system (LNG-IUS, Mirena®) without evidence of uterine
perforation. A 37-year-old Para 4+1presented with 3 months history of lower abdominal pain. Examination and
imaging showed that the device was not present in the uterine cavity. She underwent laparoscopic retrieval of
Mirena®. There was no evidence of uterine perforation intra-operatively. This case illustrated the rare possibility of
dislodged Mirena®intra-abdominally without evidence of uterine perforation. The management for missing IUS was
reviewed.
Levonorgestrel
7.Sickle Cell Disease in Pregnancy – A Rare Condition with Detrimental Outcome: A Case Report
Nik Sumayyah NMN ; Kalok A ; Nagandla K ; Shafiee MN
Medicine and Health 2017;12(2):352-356
Sickle cell disease (SCD) in pregnancy is uncommon in Malaysia. We present a case of sickle cell disease in pregnancy with maternal and fetal complications. The patient presented with acute pain crisis and hemolysis in the third trimester. Despite thromboprophylaxis, she developed deep vein thrombosis. The pregnancy was further complicated by severe pre-eclampsia and intrauterine growth restriction which require preterm caesarean section. The baby was admitted to Neonatal Intensive Care Unit due to prematurity and low birth weight. Multidisciplinary approach in managing pregnant patient with SCD is essential in achieving good obstetrics outcome.